Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02657967 · ClinicalTrials.gov registry record
Development of an Evidenced-Based Tool for Prediction of Sudden Death in Patients With Non-Ischemic Cardiomyopathy
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 57
- Enrollment target
NCT02657967 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 57 participants.
The verdict
NCT02657967 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 57 participants
- Enrollment target
Study Summary
This study is an observational study to determine predictors of sudden cardiac death or appropriate ICD therapy in patients with non-ischemic cardiomyopathy. Patients will be followed for 36 months for the occurrence of sudden cardiac death
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2015-05 |
| Est. Completion | 2019-10-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02657967
The ClinicalTrials.gov registry entry for NCT02657967 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02657967 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02657967 about?
NCT02657967 is a clinical study titled "Development of an Evidenced-Based Tool for Prediction of Sudden Death in Patients With Non-Ischemic Cardiomyopathy". This study is an observational study to determine predictors of sudden cardiac death or appropriate ICD therapy in patients with non-ischemic cardiomyopathy. Patients will be followed for 36 months for the occurrence of sudden cardiac death
What is the current status of trial NCT02657967?
This trial is currently completed. The enrollment target is 57 participants. The study started on 2015-05. Estimated completion is 2019-10-24.
Who is sponsoring clinical trial NCT02657967?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.